This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Richard Adair
Senior Virology Manager at SGS
Speaker

Profile

Dr. Richard Adair obtained his Honours degree in Immunology in 1994 from the University of Edinburgh. For the following four years he worked as a Clinical Research Manager for Procter & Gamble Technical Centres Ltd. based in Staines, but undertook management of clinical research trials in numerous international locations, including the USA and the Peoples Republic of China. As part of Richard’s training he was based at the healthcare R&D world headquarters in Cincinatti, Ohio, for six months in 1997. Richard returned to academia in 1998 to undertake a PhD in Virology at the MRC Virology Unit in Glasgow, studying the US22 gene family of human cytomegalovirus (HCMV). In March 2002, Richard undertook an NIH funded post-doctoral position at Children’s National Medical Center, Washington, DC, studying regulation of gene splicing of the UL37 gene of HCMV. In 2005 Richard returned to the UK to undertake a position as an Investigator Scientist in the MRC Virology Unit, working on hepatitis C gene regulation. In 2007 Richard joined Vitrology Limited (becoming SGS Vitrology Limited in 2012) as the Virology Manager. In 2016 he expanded his role to Virology Manager and Virology Technical Support Manager, with roles in both operations and business support. From 1st January 2022 Richard was promoted to Senior Virology Manager at SGS.

Agenda Sessions

  • Considerations for biosafety testing of cell and gene therapies

    12:15